Endosense raises funds to support porduct development


Endosense has secured an additional US$4.3 million (approximately SFr 4 million) in series C financing from a new strategic industry partner. This second successful closing brings the total in series C funds raised to US$44.6 million (approximately SFr 41.4 million). The added finances will further support the development of company's pipeline, the launch of its TactiCath Quartz contact-force sensing ablation catheter in Europe with a new direct sales force, and its programme to get access to the US market.

This article is tagged to:
Sector: Medical Devices
Geography: Switzerland, United States

Access all of our latest analysis, data and forecasts - request a trial